Loading...

뉴스 목록

뉴스 목록

For the initial treatment of HIV patients, the FDA approved the first dual-agent combination therapy

Today, the US FDA announced that it has approved the listing of the antiviral therapy Dovato (dolute

더 읽어보세요 2019-04-26
Novartis‘s Multiple sclerosis Innovative drug approved

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for th

더 읽어보세요 2019-03-29
Highly efficient trifluoromethylation and [18F]trifluoromethylation

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, ha

더 읽어보세요 2019-03-01
Redox neutral [4+1] cyclic reaction based on C-F fracture

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Techno

더 읽어보세요 2019-01-18
FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a c

더 읽어보세요 2018-12-14
FDA approves new mechanism for listing new anti-influenza drugs

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil)

더 읽어보세요 2018-11-16
FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate o

더 읽어보세요 2018-10-20
For the first time, scientists have discovered fluorine in natural conditions

Fluorine is the most reactive chemical element. That is why it is not found in nature in its element

더 읽어보세요 2018-09-20
Fluorinated antimalarial drug tafenoquine (Krintafel) approved by the US FDA

Recently, British pharmaceutical giant GlaxoSmithKline (GSK) announced that the fluorogenic anti-mal

더 읽어보세요 2018-08-14
Sanofi is approved the listing of rare disease drugs in China

Sanofi is approved in China for the treatment of a new drug for relapsing multiple sclerosis, Obajie

더 읽어보세요 2018-07-29